Kiora Pharmaceuticals Valuation
| KPRX Stock | USD 3.31 0.11 3.22% |
At this time, the firm appears to be undervalued. Kiora Pharmaceuticals secures a last-minute Real Value of $5.6 per share. The latest price of the firm is $3.31. Our model forecasts the value of Kiora Pharmaceuticals from analyzing the firm fundamentals such as Profit Margin of 0.20 %, return on equity of 0.14, and Current Valuation of (18.7 M) as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Kiora Pharmaceuticals' valuation include:
Price Book 0.3417 | Enterprise Value -18.7 M | Enterprise Value Ebitda (1.03) | Price Sales 0.6406 | Forward PE 2.4102 |
Undervalued
Today
Please note that Kiora Pharmaceuticals' price fluctuation is slightly risky at this time. Calculation of the real value of Kiora Pharmaceuticals is based on 3 months time horizon. Increasing Kiora Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Kiora Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kiora Stock. However, Kiora Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.31 | Real 5.6 | Target 12.33 | Hype 3.29 | Naive 3.02 |
The intrinsic value of Kiora Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kiora Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kiora Pharmaceuticals helps investors to forecast how Kiora stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kiora Pharmaceuticals more accurately as focusing exclusively on Kiora Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Kiora Pharmaceuticals' intrinsic value based on its ongoing forecasts of Kiora Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Kiora Pharmaceuticals' closest peers.
Kiora Pharmaceuticals Cash |
|
Kiora Valuation Trend
Analysing the historical paterns of Kiora Pharmaceuticals' enterprise value and its market capitalization is a good way to estimate and gauge the value of Kiora Pharmaceuticals over time and is usually enough for investors to make rational market timing decisions.
Kiora Pharmaceuticals Total Value Analysis
Kiora Pharmaceuticals is now projected to have valuation of (18.7 M) with market capitalization of 10.75 M, debt of 106.89 K, and cash on hands of 2.43 M. The negative valuation of Kiora Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Kiora Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(18.7 M) | 10.75 M | 106.89 K | 2.43 M |
Kiora Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Kiora is to check how much profit was generated for every dollar of assets it reports. Kiora Pharmaceuticals makes use of its assets almost 0.1296 %, making 0.13 cents for each dollar of assets held by the firm. A growing asset utilization conveys that the company is being more effective with each dollar of assets it secures. Strictly speaking, asset utilization of Kiora Pharmaceuticals shows how effective it operates for each dollar spent on its assets.Kiora Pharmaceuticals Ownership Allocation
The market capitalization of Kiora Pharmaceuticals is $10.75 Million. 30% of Kiora Pharmaceuticals outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Kiora Pharmaceuticals Profitability Analysis
Net Loss for the year was (12.51 M) with loss before overhead, payroll, taxes, and interest of (5.14 M).About Kiora Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of Kiora Pharmaceuticals. We calculate exposure to Kiora Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kiora Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -4 M | -3.8 M | |
| Pretax Profit Margin | (770.53) | (732.01) | |
| Operating Profit Margin | (780.98) | (741.93) | |
| Net Loss | (771.68) | (733.10) | |
| Gross Profit Margin | (14.04) | (14.75) |
Kiora Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 538 K | |
| Forward Price Earnings | 2.4102 |
Kiora Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Kiora Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Kiora we look at many different elements of the entity such as Kiora's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Kiora Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Kiora Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Kiora Pharmaceuticals' worth.Additional Tools for Kiora Stock Analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.